Back to Journals » Drug Design, Development and Therapy » Volume 11
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Sodium-glucose cotransporter 2 inhibitors combined with dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: a review of current clinical evidence and rationale
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
16,123 | Dovepress* | 13,701+ | 1,680 | 15,381 | |
PubMed Central* | 2,422 | 478 | 2,900 | ||
Totals | 16,123 | 2,158 | 18,281 | ||
*Since 21 March 2017 |
View citations on PubMed and Google Scholar